TerminatedPhase 4

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

Stopped: Principal Investigator is no longer at this site

United States4 participantsStarted 2013-02

Plain-language summary

The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid medications, while patients simultaneously experience progressive decline of pain along with absence of opioid withdrawal symptoms and improved quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meets DSM criteria for opioid dependence (or opioid use disorder when DSM 5 is in use) * Has received opioid therapy for at least 90 days * Has opioid dependence as assessed by a Maimonides psychiatrist Exclusion Criteria: * Scheduled for major surgery during study duration * Predicted life expectancy \< 1 year * Plan to cease habitation in greater New York area within 6 months * Risks for buprenorphine outweigh potential benefit, as determined by the PI * Lacks sufficient fluency in English to understand the study protocol, answer survey questions or give informed consent * Pregnant women

What they're measuring

Opiate Withdrawal

Timeframe: 6 months

Pain Severity

Timeframe: 6 months

Trial details

NCT IDNCT01841931

SponsorTheresa Jacob, PhD, MPH

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-07

Results submitted2018-03-23

View on ClinicalTrials.gov More Opioid Use Disorder trials